# Cell therapy for left ventricular dysfunction or heart failure
A data-only living systematic review

**Clinical summary:** This meta-analysis suggests that clinical intervention *is* effective in preserving or increasing the ejection fraction. However, there is 'substantial' heterogeneity of study results. The heterogeneity is not explained by study size, year of publication, or outcomes in the control group.

[Keep current with this topic](Keep-up.md)

**Methods overview:** This repository is an [openMetaAnalysis](https://openmetaanalysis.github.io/) that updates a previously published meta-analysis.(1) Newer studies included are listed in the references below. Rationale for newer trials excluded may be listed at the end of the references. 

This repository is a limited review and contains outcomes data only without PICO and Risk of Bias Tables.  This review does not include a GRADE Profile or Summary of Findings Table.

See [methods](http://openmetaanalysis.github.io/methods.html) for details.

**Results:** Details of the studies included are in the:
* [Forest plots](../../tree/master/forest-plots) ([source data](../../tree/master/data))

The forest plot for the primary outcome is below. Additional [forest plots](../../tree/master/forest-plots) of secondary analyses may be available. 

![Principle results](https://raw.githubusercontent.com/openMetaAnalysis/Cell-therapy-for-left-ventricular-dysfunction/master/forest-plots/Outcome-Primary.png "Principle results")

The metaregression for the primary outcome is below. Additional [metaregression plots](../../tree/master/metaregression) may be available.

![Principle results](https://raw.githubusercontent.com/openMetaAnalysis/Cell-therapy-for-left-ventricular-dysfunction/master/metaregression/Outcome-Primary.png "Principle results - metaregression")

References:
----------------------------------
### Systematic review(s)
####Most recent review(s) at time of last revision of this repository
1. Fisher SA, Doree C, Mathur A, Martin-Rendon E. Meta-Analysis of Cell Therapy Trials for Patients with Heart Failure - An Update. Circ Res. 2015 Jan 28. pii: [CIRCRESAHA.114.304386](http://dx.doi.org/CIRCRESAHA.114.304386). PMID: [25632038](http://pubmed.gov/25632038)<br/>Search date: June, 2014<br/>Number of trials: 31
1. *Nonischemic cardiomyopathy*: Marquis-Gravel G, Stevens LM, Mansour S, Avram R, Noiseux N. Stem cell therapy for the treatment of nonischemic cardiomyopathy: a systematic review of the literature and meta-analysis of randomized controlled trials. Can J Cardiol. 2014 Nov;30(11):1378-84. doi: [10.1016/j.cjca.2014.03.026](http://dx.doi.org/10.1016/j.cjca.2014.03.026). PMID: [25138483](http://pubmed.gov/25138483)
1. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev. 2014 Apr 29;4:CD007888. doi:
[10.1002/14651858.CD007888.pub2](http://dx.doi.org/10.1002/14651858.CD007888.pub2). PMID: [24777540](http://pubmed.gov/24777540).<br/>Search date: March, 2013<br/>Number of trials: 23

### Randomized controlled trials
#### New trial(s) *not* included in the most recent review above
1. *Included by converting IQRs to SDs*: Pätilä T, Lehtinen M, Vento A, at al. Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. J Heart Lung Transplant. 2014 Jun;33(6):567-74. doi: [10.1016/j.healun.2014.02.009](http://dx.doi.org/10.1016/j.healun.2014.02.009). PMID: [24656645](http://pubmed.gov/24656645)

#### New trial(s) undergoing review
1. *This is the 5-year follow-up to Pätilä*: Lehtinen M, Pätilä T, Kankuri E, Lauerma K, Sinisalo J, Laine M, Kupari M, Vento A, Harjula A; Helsinki BMMC Collaboration. Intramyocardial bone marrow mononuclear cell transplantation in ischemic heart failure: Long-term follow-up.  J Heart Lung Transplant. 2015 Feb 7. pii: S1053-2498(15)01037-2. doi:
[10.1016/j.healun.2015.01.989](http://dx.doi.org/10.1016/j.healun.2015.01.989). PMID: [25797522](http://pubmed.gov/25797522)


#### New trial(s) *excluded* 
1. *LVEF reported as insignificant, but numbers not reported*: Perin EC, Sanz-Ruiz R, Sánchez PL et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial.
Am Heart J. 2014 Jul;168(1):88-95.e2. doi: [10.1016/j.ahj.2014.03.022](http://dx.doi.org/10.1016/j.ahj.2014.03.022). PMID: [24952864](http://pubmed.gov/24952864) [NCT00426868](https://clinicaltrials.gov/ct2/show/NCT00426868)

-------------------------------
[Cite and use this content](https://github.com/openMetaAnalysis/openMetaAnalysis.github.io/blob/master/reusing.MD)  - [Edit this page](../../edit/master/README.md) - [History](../../commits/master/README.md)  - 
[Issues and comments](../../issues?q=is%3Aboth+is%3Aissue)

